These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7702758)
1. A beta-galactosidase expression vector for promoter analysis. Park J; Collier P; Chen E; Gibson CW DNA Cell Biol; 1994 Nov; 13(11):1147-9. PubMed ID: 7702758 [TBL] [Abstract][Full Text] [Related]
2. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter. Tanaka S; Iwai M; Harada Y; Morikawa T; Muramatsu A; Mori T; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O Cancer Gene Ther; 2000 Sep; 7(9):1241-50. PubMed ID: 11023196 [TBL] [Abstract][Full Text] [Related]
3. An insertion vector for the analysis of gene expression during herpes simplex virus infection. Weir JP; Steffy KR; Sethna M Gene; 1990 May; 89(2):271-4. PubMed ID: 2165021 [TBL] [Abstract][Full Text] [Related]
4. A sensitive lacZ-based expression vector for analyzing transcriptional control elements in eukaryotic cells. Spear BT; Longley T; Moulder S; Wang SL; Peterson ML DNA Cell Biol; 1995 Jul; 14(7):635-42. PubMed ID: 7626223 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor growth by direct intratumoral gene transfer of herpes simplex virus thymidine kinase gene with DNA-liposome complexes. Sugaya S; Fujita K; Kikuchi A; Ueda H; Takakuwa K; Kodama S; Tanaka K Hum Gene Ther; 1996 Jan; 7(2):223-30. PubMed ID: 8788173 [TBL] [Abstract][Full Text] [Related]
6. The pKSM710 vector cassette provides tightly regulated lac and T7lac promoters and strategies for manipulating N-terminal protein sequences. Maneewannakul S; Maneewannakul K; Ippen-Ihler K Plasmid; 1994 May; 31(3):300-7. PubMed ID: 8058823 [TBL] [Abstract][Full Text] [Related]
7. A novel nonviral cytoplasmic gene expression system and its implications in cancer gene therapy. Chen X; Li Y; Xiong K; Xie Y; Aizicovici S; Snodgrass R; Wagner TE; Platika D Cancer Gene Ther; 1995 Dec; 2(4):281-9. PubMed ID: 8548582 [TBL] [Abstract][Full Text] [Related]
8. Effect of the rabbit alphas1-casein gene distal enhancer on the expression of a reporter gene in vitro and in vivo. Pantano T; Jolivet G; Prince S; Menck-Le Bourhis C; Maeder C; Viglietta C; Rival S; Houdebine LM Biochem Biophys Res Commun; 2002 Jan; 290(1):53-61. PubMed ID: 11779132 [TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid regulation of a transcription factor that binds an initiator-like element in the murine thymidine kinase (Tk-1) promoter. Rhee K; Thompson EA Mol Endocrinol; 1996 Dec; 10(12):1536-48. PubMed ID: 8961264 [TBL] [Abstract][Full Text] [Related]
10. Transfection with the isolated herpes simplex virus thymidine kinase genes. I. Minimal size of the active fragments from HSV-1 and HSV-2. Reyes GR; Jeang KT; Hayward GS J Gen Virol; 1982 Oct; 62 (Pt 2)():191-206. PubMed ID: 6292348 [TBL] [Abstract][Full Text] [Related]
11. Characterization of eukaryotic transcriptional control signals by assay of herpes simplex virus type 1 thymidine kinase. Lang JC; Wilkie NM; Spandidos DA J Gen Virol; 1983 Dec; 64 ( Pt 12)():2679-96. PubMed ID: 6319553 [TBL] [Abstract][Full Text] [Related]
12. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors. Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453 [TBL] [Abstract][Full Text] [Related]
13. Insertion of DNA sequences at a unique restriction enzyme site engineered for vector purposes into the genome of herpes simplex virus type 1. Rixon FJ; McLauchlan J J Gen Virol; 1990 Dec; 71 ( Pt 12)():2931-9. PubMed ID: 2177085 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of transient gene expression with plasmids encoding herpes simplex virus type 1 UL55 and alpha genes. Block T; Jordan R; Farkas DH; Hughes RG J Gen Virol; 1991 Jan; 72 ( Pt 1)():131-41. PubMed ID: 1846642 [TBL] [Abstract][Full Text] [Related]
15. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter]. Zhou HK; Yang DH; Tang SH; Huang W; Lu XH Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715 [TBL] [Abstract][Full Text] [Related]
16. A myxoma virus intergenic transient dominant selection vector. Jackson RJ; Bults HG J Gen Virol; 1992 Dec; 73 ( Pt 12)():3241-5. PubMed ID: 1469364 [TBL] [Abstract][Full Text] [Related]
17. A herpes simplex virus-1 vector containing the rat tyrosine hydroxylase promoter directs cell type-specific expression of beta-galactosidase in cultured rat peripheral neurons. Oh YJ; Moffat M; Wong S; Ullrey D; Geller AI; O'Malley KL Brain Res Mol Brain Res; 1996 Jan; 35(1-2):227-36. PubMed ID: 8717359 [TBL] [Abstract][Full Text] [Related]
19. [Cloning of human telomerase reverse transcriptase promoter for targeted cancer therapy]. Li F; Tan XH; Peng XJ; Cai HB; Hu DR Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):207-11. PubMed ID: 15699008 [TBL] [Abstract][Full Text] [Related]
20. An in vitro ligation and transfection system for inserting DNA sequences into the latency-associated transcripts (LATs) gene of herpes simplex virus type 1. Huang QS; Deshmane SL; Fraser NW Gene Ther; 1994 Sep; 1(5):300-6. PubMed ID: 7584095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]